Ultrasound Tech Maps Chest Vibrations for Improved Diagnosis
A team of French researchers demonstrated the efficacy of ultrasound technology to detect low-amplitude movements produced by vocalizations at the surface of the chest.
A team of French researchers demonstrated the efficacy of ultrasound technology to detect low-amplitude movements produced by vocalizations at the surface of the chest.
Using a new technology developed at MIT, diagnosing lung cancer could become as easy as inhaling nanoparticle sensors and then taking a urine test that reveals whether a tumor is present.
Diagnosing early-stage lung cancer with low-dose computed tomography screening drastically improves its cure rate measured over a 20-year period, according to a large-scale study.
LUNGevity Foundation has launched an Early Lung Cancer Center to accelerate the development and broad adoption of early detection and treatment options.
Read MoreA UC San Francisco-led study finds the current definition of chronic tobacco-related lung diseases leaves patients undiagnosed and untreated.
Read MoreThe latest blood gas analyzers on the market from Instrumentation Laboratory, Nova Biomedical, Radiometer America, and Siemens Healthineers.
Read MoreNew research suggests that despite showing clear symptoms of COPD, many African Americans are not officially diagnosed with the disease due flaws in diagnosis methods.
Read MoreThe company announced a voluntary field corrective action to address complaints of endobronchial combustion occurring when laser-compatible bronchoscopes are used during therapeutic procedures in combination with laser therapy equipment or argon plasma coagulation.
Read MoreThe clearance allows FebriDx to be marketed in the United States for use by healthcare professionals as an aid in the diagnosis of bacterial acute respiratory infection and differentiation from non-bacterial etiology in patients presenting in urgent care or emergency care settings.
Read MoreA newly developed PET imaging agent can non-invasively identify pulmonary fibrosis in its early stages, reducing the need for unnecessary biopsies and allowing patients to begin treatment sooner.
Read MoreCaire’s Fenom Pro fractional exhaled nitric oxide (FeNO) device can now be upgraded to include a 6-second test mode available for ages 6 and up.
Read MoreThe tool, which has been granted FDA Breakthrough Device Designation, is being developed to serve as adjunct in assessment of ILD, potentially avoiding expensive, invasive surgical testing.
Read MoreAccording to Hologic, the test will be a critical tool this upcoming season to help clinicians determine which respiratory virus or coinfection patients have to better inform the best course of treatment.
Read MoreThe test can help physicians diagnose long COVID, differentiate it from diseases with similar symptoms, and provide insights into personalized treatment approaches.
Read MoreWhen compared to PCR, the gold standard COVID test, breathalyzer results matched 85% of the time. For medical diagnostics, accuracy of 80% or greater is considered “excellent.”
Read More